{"ATC Code":["N - Nervous system","N06 - Psychoanaleptics","N06B - Psychostimulants, agents used for adhd and nootropics","N06BX - Other psychostimulants and nootropics","N06BX11 - Aniracetam","QN - Nervous system","QN06 - Psychoanaleptics","QN06B - Psychostimulants, agents used for adhd and nootropics","QN06BX - Other psychostimulants and nootropics","QN06BX11 - Aniracetam"],"Aliases":["Draganon","Sarpul","1-(4-Methoxybenzoyl)-2-pyrrolidinone","Ro 13-5057","1-p-Anisoyl-2-pyrrolidinone","Ro-13-5057","1-anisoyl-2-pyrrolidinone","1-p-anisoylpyrrolidin-2-one","NSC-758223","Ro-135057","Dtxcid3025128","Chebi:47943","1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one","1-((4-methoxyphenyl)carbonyl)pyrrolidin-2-one","aniracetamum","N06BX11","Ampamet","2-Pyrrolidinone, 1-(4-methoxybenzoyl)-","Mfcd00153767","Mls000079240","aniracetam;p-methoxybenzoyl-2-pirrolidone","Ncgc00015116-10","Smr000038438","Aniracetamun","Memodrin","Cas-72432-10-1","Sr-01000003147","Ro 135057","Brn 4807205","Sarpol","Reset","Draganon;","Ampamet;","Reset;","1-(p-Methoxybenzoyl)-2-pyrrolidinon","Spectrum_001342","Tocris-0867","Aniracetam, \u003e=98%","Opera_ID_294","Spectrum3_001553","Spectrum4_000761","Spectrum5_001609","Lopac-A-9950","Biomol-NT_000222","Lopac0_000115","Schembl70998","BSPBio_003026","KBioGR_001142","KBioSS_001822","Mls000028591","Mls001201800","Chembl36994","DivK1c_000403","Spectrum1503078","Aniracetam - Bio-X trade mark","BPBio1_001316","GTPL4133","orb1224140","orb1310712","Schembl11379053","HMS501E05","KBio1_000403","KBio2_001822","KBio2_004390","KBio2_006958","KBio3_002526","Ninds_000403","GLXC-06465","HMS2089O17","HMS2094K07","HMS2234E11","HMS3260G12","HMS3266L08","HMS3411P17","HMS3657G11","HMS3675P17","HMS3713N20","HMS3884C09","HMS5079L05","Pharmakon1600-01503078","MSK10891","Tox21_110086","Tox21_500115","1-(4-Methoxybenzoyl)-2-pyrrolidone","HB0116","HY-10932R","NSC758223","s1281","1-(p-methoxybenzoyl)-2-pyrrolidinone","Akos005066313","Tox21_110086_1","AB04115","CCG-204210","CS-1793","DB04599","FA17937","KS-5313","LP00115","NSC 758223","Sdccgsbi-0050103.p005","Idi1_000403","Ncgc00015116-01","Ncgc00015116-02","Ncgc00015116-03","Ncgc00015116-04","Ncgc00015116-05","Ncgc00015116-06","Ncgc00015116-07","Ncgc00015116-08","Ncgc00015116-09","Ncgc00015116-11","Ncgc00015116-12","Ncgc00015116-13","Ncgc00015116-24","Ncgc00021402-02","Ncgc00021402-05","Ncgc00021402-06","Ncgc00021402-07","Ncgc00021402-08","Ncgc00260800-01","Ro-13-3057","1-(4-Methoxy-benzoyl)-pyrrolidin-2-one","1-(4-Methoxybenzoyl)-2-pyrrolidinone #","AC-15651","BA164183","HY-10932","SY052612","Sbi-0050103.p004","A2394","A5326","EU-0100115","NS00017748","SW199095-2","A 9950","D01883","H10883","Ab00053303-14","Ab00053303_15","Ab00053303_16","Aniracetam; 1-p-anisoyl-2-pyrrolidinone","F859371","Sr-01000003147-2","Sr-01000003147-4","Sr-01000003147-6","Sr-01000003147-8","Brd-k88611939-001-02-6","Brd-k88611939-001-13-3","Brd-k88611939-001-22-4","Brd-k88611939-001-23-2"],"Biological Half-Life":"1-2.5 hours","CAS":"72432-10-1","ChemicalClasses":["racetam"],"Chirality":"achiral","DTXSID":"5045128","Druglikeness":{"Lipinski":{"Passes":true,"Violations":0}},"EliminationHalfLife":"0.5 hours\u003ca href='#cite_note-2'\u003e\u003csup\u003e[2]\u003c/sup\u003e\u003c/a\u003e","Erowid Experience Reports":[],"Esters":[],"European Community (EC) Number":"615-758-3","Formating":[],"HMDB ID":"HMDB0248441","HeavyAtomCount":16,"IUPACName":"1-(4-methoxybenzoyl)pyrrolidin-2-one","InChI":"InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3","InChIKey":"ZXNRTKGTQJPIJK-UHFFFAOYSA-N","MeSH Headers":[{"Id":"M0111076","Link":"https://id.nlm.nih.gov/mesh/M0111076.html","Name":"aniracetam","Ref":60},{"Id":"M0111074","Link":"https://id.nlm.nih.gov/mesh/M0111074.html","Name":"Ro 13-5057","Ref":62},{"Id":"DescTree","Link":"https://www.nlm.nih.gov/mesh/meshhome.html","Name":"MeSH Tree","Ref":63},{"Id":"PubMed from MeSH","Link":"https://www.nlm.nih.gov/mesh/meshhome.html","Name":null,"Ref":83},{"Id":"M0001384","Link":"https://id.nlm.nih.gov/mesh/M0001384.html","Name":"Antidepressive Agents","Ref":84},{"Id":"M0028009","Link":"https://id.nlm.nih.gov/mesh/M0028009.html","Name":"Nootropic Agents","Ref":85}],"MeSH Pharmacological Classification":[{"Id":"M0001384","Link":"https://id.nlm.nih.gov/mesh/M0001384.html","Name":"Antidepressive Agent","Ref":84},{"Id":"M0028009","Link":"https://id.nlm.nih.gov/mesh/M0028009.html","Name":"Nootropic Agent","Ref":85}],"MolecularFormula":"C\u003csub\u003e12\u003c/sub\u003eH\u003csub\u003e13\u003c/sub\u003eNO\u003csub\u003e3\u003c/sub\u003e","MolecularWeight":"219.24 g/mol","Passes":true,"Pharmacodynamics":"Aniracetam possesses a wide range of anxiolytic properties, which may be mediated by an interaction between cholinergic, dopaminergic and serotonergic systems.","PubChemId":2196,"PubChemTitle":"Aniracetam","RefChem":"558129","RefCount":3,"RefCur":"","References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Aniracetam","Name":"Aniracetam","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q417630","Name":"Aniracetam","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/DB04599","Name":"Aniracetam","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/2196","Name":"Aniracetam","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=72432-10-1","Name":"Aniracetam","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0248441","Name":"Aniracetam","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/D01883","Name":"Aniracetam","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/5L16LKN964","Name":"Aniracetam","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5045128","Name":"Aniracetam","Sub":false}]}],"Refs":["National Center for Biotechnology Information. PubChem Compound Summary for CID 2196, Aniracetam. Accessed June 12, 2026. \u003ca href=https://pubchem.ncbi.nlm.nih.gov/compound/2196\u003ehttps://pubchem.ncbi.nlm.nih.gov/compound/2196\u003c/a\u003e","Roncari G. Human Pharmacokinetics of Aniracetam. Drug Investigation. June 1, 1993; 5(S1):68–72."],"SMILES":"COC1=CC=C(C=C1)C(=O)N2CCCC2=O","SaltData":[],"Salts":[],"Scheduling":[{"gov":"Australia","ref":[],"schedule":"S4 substance"}],"StereoisomerData":[],"Stereoisomers":[],"Structure":"\u003csvg xmlns=\"http://www.w3.org/2000/svg\" preserveAspectRatio=\"none\" style=\"display:block\" viewBox=\"0 0 85.384 86.761\"\u003e\u003crect width=\"100%\" height=\"100%\" fill=\"#fff\"/\u003e\u003cdesc\u003eGenerated by the Chemistry Development Kit (http://github.com/cdk)\u003c/desc\u003e\u003cg fill=\"#ff0d0d\" stroke=\"#000\" stroke-linecap=\"round\" stroke-linejoin=\"round\" stroke-width=\".8\"\u003e\u003cpath fill=\"#fff\" stroke=\"none\" d=\"M0 0h86v87H0z\"/\u003e\u003cg class=\"mol\"\u003e\u003cpath d=\"m82.31.965.146 11.046M78.933 18.333l-9.519 5.664\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m69.414 23.997-13.753-7.552M66.983 25.444l-11.271-6.189\"/\u003e\u003c/g\u003e\u003cpath d=\"m55.661 16.445-12.866 7.683\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m42.795 24.128.075 15.24M45.241 25.508l.061 12.456\"/\u003e\u003c/g\u003e\u003cpath d=\"m42.87 39.368 12.941 7.556\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m55.811 46.924 13.678-7.687M55.834 44.114l11.21-6.3\"/\u003e\u003c/g\u003e\u003cpath d=\"m69.414 23.997.075 15.24M42.87 39.368l-13.198 7.62\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"m29.672 48.396-10.199-5.889M30.891 46.284l-10.199-5.889\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"m19.473 42.507 5.099 2.944M20.692 40.395l5.099 2.945\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath d=\"M29.672 46.988v11.139M32.854 64.569l9.112 6.701M41.966 71.27l-4.674 14.428M37.292 85.698h-15.24M22.052 85.698 17.379 71.27M26.49 64.569l-9.111 6.701\" class=\"bond\"/\u003e\u003cg class=\"bond\"\u003e\u003cpath d=\"M17.842 72.701 6.335 68.993M18.59 70.38 7.083 66.672\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"m6.335 68.993 5.753 1.854M7.083 66.672l5.754 1.854\" class=\"hi\"/\u003e\u003c/g\u003e\u003cpath stroke=\"none\" d=\"M82.514 14.159q-.738 0-1.173.554-.428.547-.428 1.494 0 .946.428 1.494.435.548 1.173.548t1.167-.548q.428-.548.428-1.494 0-.947-.428-1.494-.429-.554-1.167-.554m0-.548q1.054 0 1.679.709.631.702.631 1.887 0 1.179-.631 1.887-.625.703-1.679.703t-1.685-.703q-.631-.702-.631-1.887t.631-1.887q.631-.709 1.685-.709M16.477 37.323q-.738 0-1.173.554-.428.547-.428 1.494t.428 1.494q.435.548 1.173.548t1.167-.548q.428-.547.428-1.494t-.428-1.494q-.429-.554-1.167-.554m0-.548q1.054 0 1.679.709.631.702.631 1.887 0 1.179-.631 1.887-.625.703-1.679.703t-1.685-.703q-.631-.702-.631-1.887t.631-1.887q.631-.709 1.685-.709\" class=\"atom\"/\u003e\u003cpath fill=\"#3050f8\" stroke=\"none\" d=\"M27.779 59.728h.911l2.214 4.185v-4.185h.661v5h-.911l-2.22-4.185v4.185h-.655z\" class=\"atom\"/\u003e\u003cpath stroke=\"none\" d=\"M2.876 64.552q-.738 0-1.173.554-.429.547-.429 1.494t.429 1.494q.435.548 1.173.548t1.167-.548q.428-.547.428-1.494t-.428-1.494q-.429-.554-1.167-.554m0-.548q1.053 0 1.679.709.631.702.631 1.887 0 1.179-.631 1.887-.626.703-1.679.703-1.054 0-1.685-.703Q.56 67.785.56 66.6t.631-1.887q.631-.709 1.685-.709\" class=\"atom\"/\u003e\u003cpath stroke=\"#ff0d0d\" d=\"m82.456 12.011-.073-5.523M78.933 18.333l-4.759 2.832\" class=\"hi\"/\u003e\u003cpath stroke=\"#3050f8\" d=\"M29.672 58.127v-5.569M32.854 64.569l4.556 3.35M26.49 64.569l-4.556 3.35\" class=\"hi\"/\u003e\u003c/g\u003e\u003c/g\u003e\u003c/svg\u003e","Title":"Aniracetam","UNII":"5L16LKN964","Violations":0,"Wikidata":"Q417630","Wikipedia":"Aniracetam","XLogP":1.6}
